CD8A and cancer: Inhibiting TNFR2 in this manner could have a significant impact on the TME, by suppressing cancer cell growth, limiting angiogenesis, preventing metastasis, restoring TAA presentation by DC1s, and enhancing NK cell and CD8+ T cell function (Fig. 11).